Skip to main content
CRL
NYSE Industrial Applications And Services

Charles River Beats Q3, Raises 2026 Guidance; Non-GAAP EPS Up 27.2%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$362.009
Mkt Cap
$16.798B
52W Low
$146.195
52W High
$379.63
52W Position info
148% above low
Off High info
4.6% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CRL has more than doubled off its 52-week low of $146.195.

Summary

Charles River beat third-quarter expectations with 4.7% organic revenue growth and $3.09 non-GAAP EPS, then raised 2026 organic revenue and non-GAAP EPS guidance. The GAAP EPS of $6.86 includes a $5.06 per-share tax-reserve reversal.


Key Events · Earnings and Guidance · CRL

  • Q3 Beat With 4.7% Organic Growth

    Revenue of $982.7 million was down 2.2% reported on divestitures but up 4.7% organically, with DSA organic revenue up 5.9% on higher regulated safety assessment study volume.

  • Non-GAAP EPS Up 27.2%

    Non-GAAP EPS of $3.09 rose from $2.43, and non-GAAP operating margin expanded 330 basis points to 23.0% on the CDMO divestiture and operating leverage.

  • GAAP EPS Inflated by Tax Reversal

    GAAP EPS of $6.86 includes a $245.6 million, or $5.06 per share, benefit from reversing acquired tax reserves after new tax legislation and completion of foreign tax requirements.

  • 2026 Guidance Raised

    Organic revenue growth guidance rises to at least +1.5% from 0.0%-1.0%, and non-GAAP EPS guidance rises $0.15 at the midpoint to $11.35-$11.55; GAAP EPS guidance moves to $8.15-$8.35 from $3.05-$3.35.


Analysis · CRL · Industrial Applications And Services

Charles River delivered a clean beat and raised full-year guidance for the second straight quarter, with organic growth of 4.7% and non-GAAP operating margin up 330 basis points to 23.0%. The headline GAAP EPS of $6.86 is inflated by a $245.6 million ($5.06 per share) reversal of acquired tax reserves, so the $3.09 non-GAAP figure is the cleaner read on operations. Management now expects at least 1.5% organic revenue growth for 2026 versus 0.0%-1.0% before, and lifted non-GAAP EPS guidance by $0.15 at the midpoint to $11.35-$11.55. The beat was led by the DSA segment, where organic revenue rose 5.9% on higher regulated safety assessment study volume, and by a lower tax rate. This follows the September 24 Investor Day, where the company reaffirmed guidance at the upper end and set long-term targets through 2030.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRL was trading at $362.01 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $16.8B. The 52-week trading range was $146.20 to $379.63. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRL - Latest Insights

CRL
Nov 09, 2026, 6:10 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $337.44
Real-time Price: $325.80 info
Change: -$11.64 (-3%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $325.80 info
Change: -$17.19 (-5%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $362.00
Real-time Price: $325.80 info
Change: -$36.20 (-10%) info
Market Cap: $15.714B info
CRL
Sep 24, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $278.01
Real-time Price: $325.80 info
Change: +$47.79 (+17%) info
Market Cap: $15.714B info
CRL
Sep 24, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $277.33
Real-time Price: $325.80 info
Change: +$48.47 (+17%) info
Market Cap: $15.714B info